HYA Advisors’s Bristol-Myers Squibb BMY Stock Holding History

HYA Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$236K	Buy	3,059 +9	+0.3%	+$685	0.09%	131
2022 Q1	$223K	Buy	+3,050	New	+$205K	0.08%	143
2021 Q3	–	Sell	-3,252	Closed	-$217K	–	152
2021 Q2	$217K	Sell	3,252 -199	-6%	-$13K	0.09%	139
2021 Q1	$218K	Buy	3,451 +11	+0.3%	+$684	0.1%	132
2020 Q4	$213K	Sell	3,440 -136	-4%	-$8.36K	0.11%	122
2020 Q3	$216K	Sell	3,576 -86	-2%	-$5.18K	0.13%	114
2020 Q2	$215K	Buy	3,662 +12	+0.3%	+$718	0.14%	110
2020 Q1	$203K	Sell	3,650 -348	-9%	-$21.3K	0.17%	99
2019 Q4	$257K	Buy	+3,998	New	+$229K	0.16%	94

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HYA Advisors's BMY Position: Q2 2022 in Review

HYA Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.3% in Q2 2022, buying an estimated $685 and bringing the position to 3,059 shares worth $236K. The position accounts for 0.09% of the portfolio, ranked #131.

HYA Advisors first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $257K in Q4 2019. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

HYA Advisors held 3,059 shares of Bristol-Myers Squibb worth $236K as of Q2 2022.
HYA Advisors bought 9 Bristol-Myers Squibb shares in Q2 2022, an estimated $685.
Bristol-Myers Squibb made up 0.09% of HYA Advisors's portfolio in Q2 2022, its #131 holding.
HYA Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
HYA Advisors's Bristol-Myers Squibb position peaked at $257K in Q4 2019.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on HYA Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.